Switching From Natalizumab To Immune Reconstitution Therapies In Patients With Multiple Sclerosis

被引：0
|
作者：
Matos, Sara [1 ]
Cunha, Carolina [1 ]
Bernardes, Catarina [1 ]
Cardoso, Joao [2 ]
Campelo, Isabel [2 ]
Feio, Jose [2 ]
Batista, Sonia [1 ,3 ]
Nunes, Carla [1 ]
Macario, Maria do Carmo [1 ,3 ]
Sousa, Livia Maria [1 ,3 ]
Correia, Ines [1 ,3 ]
机构：
[1] Coimbra Univ Hosp Ctr, Neurol, Coimbra, Portugal
[2] Coimbra Univ Hosp Ctr, Hosp Pharm, Coimbra, Portugal
[3] Coimbra Univ, Fac Med, Coimbra, Portugal
来源：
MULTIPLE SCLEROSIS JOURNAL | 2023年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1464/1365
引用
收藏
页码：931 / 931
页数：1
相关论文
共 50 条
  • [41] Immune surveillance of the central nervous system in multiple sclerosis patients treated with natalizumab
    Stuve, Olaf
    Marra, Christina M.
    Jerome, Keith R.
    Cook, Linda
    Cravens, Petra D.
    Cepok, Sabine
    Frohman, Elliot
    Phillips, Theodore
    Arendt, Gabriele
    Hemmer, Bernhard
    Monson, Nancy
    Racke, Michael
    JOURNAL OF NEUROIMMUNOLOGY, 2006, 178 : 54 - 54
  • [42] Reversibility of Natalizumab Effects on Peripheral Immune Cell Dynamics in Patients with Multiple Sclerosis
    Amarante, D.
    Plavina, T.
    Muralidharan, K. K.
    Kuesters, G.
    Mikol, D.
    Evans, K.
    Subramanyam, M.
    Nestorov, I.
    Chen, Y.
    Dong, Q.
    Ho, P-R
    De Seze, J.
    Fox, R.
    Gold, R.
    Jeffery, D.
    Kappos, L.
    Montalban, X.
    Weinstock-Guttman, B.
    Hartung, H-P
    Cree, Bruce A. C.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 (02) : 336 - 337
  • [43] Natalizumab effects on immune cell responses in multiple sclerosis
    Niino, M.
    Bodner, C.
    Simard, M. L.
    Alatab, S.
    Gano, D.
    Kim, H. J.
    Trigueiro, M.
    Racicot, D.
    Guerette, C.
    Antel, J. P.
    Fournier, A.
    Grand'Maison, F.
    Bar-Or, A.
    JOURNAL OF NEUROIMMUNOLOGY, 2006, 178 : 210 - 210
  • [44] Natalizumab effects on immune cell responses in multiple sclerosis
    Niino, M
    Bodner, C
    Simard, ML
    Alatab, S
    Gano, D
    Kim, HJ
    Trigueiro, M
    Racicot, D
    Guérette, C
    Antel, JP
    Fournier, A
    Grand'Maison, F
    Bar-Or, A
    ANNALS OF NEUROLOGY, 2006, 59 (05) : 748 - 754
  • [45] Pulsed immune reconstitution therapy in multiple sclerosis
    Sorensen, Per Soelberg
    Sellebjerg, Finn
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2019, 12
  • [46] Persistence of Neutralizing Antibodies Against Interferon Beta in Multiple Sclerosis Patients Switching to Natalizumab
    Lundkvist, Malin
    Sominanda, Ajith
    Hillert, Jan
    Fogdell-Hahn, Anna
    NEUROLOGY, 2010, 74 (09) : A417 - A417
  • [47] Switching disease modifying therapies in multiple sclerosis patients: a study of 110 patients
    Morra, VB
    Coppola, G
    Lanzillo, R
    Vacca, G
    Pagano, A
    Orefice, G
    MULTIPLE SCLEROSIS, 2004, 10 (7032): : S235 - S235
  • [48] Switching disease modifying therapies in multiple sclerosis patients: a study on 110 patients
    Morra, VB
    Coppola, G
    Vacca, G
    Longobardi, M
    Ascione, S
    Schiavone, V
    Pagano, A
    Bonavita, V
    Orefice, G
    JOURNAL OF NEUROLOGY, 2004, 251 : 88 - 88
  • [49] Escalation to natalizumab or switching among immunomodulators in relapsing multiple sclerosis
    Prosperini, Luca
    Gianni, Costanza
    Leonardi, Laura
    De Giglio, Laura
    Borriello, Giovanna
    Galgani, Simonetta
    Pozzilli, Carlo
    Gasperini, Claudio
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 (01) : 64 - 71
  • [50] Assessment of immune functions and MRI disease activity in relapsing-remitting multiple sclerosis patients switching from natalizumab to fingolimod (ToFingo-Successor)
    Klotz, Luisa
    Gruetzke, Berit
    Eveslage, Maria
    Deppe, Michael
    Gross, Catharina C.
    Kirstein, Lucienne
    Posevitz-Fejfar, Anita
    Schneider-Hohendorf, Tilman
    Schwab, Nicholas
    Meuth, Sven G.
    Wiendl, Heinz
    BMC NEUROLOGY, 2015, 15
12345